Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F37HrbNj1ryJ11NnxJYMs_NP7dIQ.uncropped.jpg&w=3840&q=75)
Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page
- ChecktodayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.0%
- Check28 days agoChange DetectedDifference0.1%
- Check35 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and replaced it with a definitive 'Last Update Posted' indicator.SummaryDifference0.0%
- Check37 days agoChange DetectedA new study on Zolbetuximab (IMAB362) for treating advanced gastric and gastroesophageal junction cancer has been added, focusing on its effectiveness and safety, while a previous study assessing its antitumor activity and pharmacokinetics has been removed.SummaryDifference11%
- Check43 days agoChange DetectedThe website has been updated to version v2.10.0, adding 5 more interventions/treatments and noting that the study now has 26 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.2%
Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.